Related Experiment Video
Updated: Nov 13, 2025
Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System
Published on: July 21, 2015
Limitations of animal epilepsy research models: Can epileptic human tissue provide translational benefit?
Gareth Morris1,2, Rachel Rowell3, Mark Cunningham2,4
1Department of Physiology & Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland.
Abstract:
Advancement of understanding the etiology and treatment of epilepsy has largely depended on the use of acute and chronic animal models. An alternative approach, which is being increasingly used by a select number of laboratories worldwide, is to perform functional mechanistic studies in brain slices of living human tissue resected during surgery for drug resistant epilepsies. Pharmacoresistant epilepsy is a major clinical problem with a significant proportion of patients not receiving any symptomatic benefit from available anti-epileptic drugs. Animal models of epilepsy have dominated the landscape with regard to research and development, however they have failed to deliver new agents that would provide seizure control in patients with drug refractory epilepsy. Moreover, these models have considerable issues with respect to validity and animal welfare considerations. A compelling alternative is the use of live human epileptic tissue, which recapitulates a number of key features of refractory epilepsy. The use of live epileptic human tissue offers unprecedented opportunities to understand the mechanisms associated with difficult to treat epilepsy whilst also permitting studies of efficacy of novel agents that are being developed to alleviate epilepsy in drug resistant patients.
Insights
Functional studies using living human epileptic brain tissue offer a promising alternative to animal models for understanding and treating drug-resistant epilepsy. This approach provides unique insights into refractory epilepsy mechanisms and novel anti-epileptic drug efficacy.
Area of Science:
- Neuroscience
- Epileptology
- Pharmacology
Background:
- Drug-resistant epilepsy affects many patients, with limited success from current anti-epileptic drugs.
- Animal models have historically dominated epilepsy research but have shown limited success in developing new treatments for refractory cases.
- Existing animal models present challenges in validity and animal welfare.
Purpose of the Study:
- To explore the utility of functional mechanistic studies in living human epileptic brain tissue as an alternative to animal models.
- To investigate the potential of using resected human epileptic tissue for understanding drug-resistant epilepsy.
- To evaluate the efficacy of novel anti-epileptic agents in a human tissue model.
Main Methods:
- Performing functional mechanistic studies on brain slices from living human tissue.
- Utilizing tissue resected during surgery for drug-resistant epilepsies.
- Investigating key features of refractory epilepsy in human brain slices.
Main Results:
- Living human epileptic tissue recapitulates critical features of refractory epilepsy.
- This approach allows for direct study of mechanisms underlying difficult-to-treat epilepsy.
- The model enables assessment of novel anti-epileptic agent efficacy in drug-resistant patients.
Conclusions:
- Functional studies with live human epileptic tissue represent a compelling alternative to animal models.
- This methodology offers unprecedented opportunities to advance epilepsy research and drug development.
- The use of human tissue holds significant promise for improving outcomes in patients with pharmacoresistant epilepsy.
